These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3144125)
1. In vitro effects of chemotactic factors on eosinophil Fc and complement receptor expression. Walsh GM; Moqbel R; Wardlaw AJ; Kay AB Acta Paediatr Jpn; 1987 Oct; 29(5):672-7. PubMed ID: 3144125 [No Abstract] [Full Text] [Related]
2. The influence of chemotactic factors on the expression of phagocyte receptors. Glass EJ; Stewart J; Weir DM J Clin Lab Immunol; 1982 Jan; 7(1):39-41. PubMed ID: 7069777 [No Abstract] [Full Text] [Related]
3. Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor. Capron M; Capron A; Goetzl EJ; Austen KF Nature; 1981 Jan; 289(5793):71-3. PubMed ID: 7453810 [TBL] [Abstract][Full Text] [Related]
4. The effects of substance P on human eosinophil receptors and functions. De Simone C; Ferrari M; Ferrarelli G; Rumi C; Pugnaloni L; Sorice F Ann N Y Acad Sci; 1987; 496():226-32. PubMed ID: 2440367 [No Abstract] [Full Text] [Related]
5. Leukocyte chemotactic factors and the C3b receptor. Kay AB; Duncan AJ; Glass EJ; Stewart J Kroc Found Ser; 1981; 14():197-211. PubMed ID: 6458667 [No Abstract] [Full Text] [Related]
6. Effects of mononuclear phagocyte system modulating agents on Fc and C3 receptors of adherent cells. Hitomi M; Shimizu F Br J Exp Pathol; 1985 Jun; 66(3):371-6. PubMed ID: 2408651 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of areca nut extract on expression of complement receptors and fc receptors in human neutrophils. Lee YY; Lin MB; Cheng CF; Chang LY; Liu TY; Hung SL J Periodontol; 2014 Aug; 85(8):1096-106. PubMed ID: 24354650 [TBL] [Abstract][Full Text] [Related]
8. Comparative studies on eosinophil chemotactic factors during leukocyte migration under agarose. Fischer N; Czarnetzki BM J Invest Dermatol; 1982 Oct; 79(4):222-6. PubMed ID: 7130738 [TBL] [Abstract][Full Text] [Related]
9. Immunologic evaluation of patients with polychlorinated biphenyl poisoning: determination of phagocyte Fc and complement receptors. Chang KJ; Hsieh KH; Lee TP; Tung TC Environ Res; 1982 Aug; 28(2):329-34. PubMed ID: 6811262 [No Abstract] [Full Text] [Related]
10. Effect of neuraminidase on Fc and C3b receptors on rabbit corneal cells infected with herpes simplex virus. Hatano H; Oh JO Curr Eye Res; 1987 Jan; 6(1):53-7. PubMed ID: 3829705 [TBL] [Abstract][Full Text] [Related]
11. RANTES is a chemotactic and activating factor for human eosinophils. Alam R; Stafford S; Forsythe P; Harrison R; Faubion D; Lett-Brown MA; Grant JA J Immunol; 1993 Apr; 150(8 Pt 1):3442-8. PubMed ID: 7682241 [TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro effects of doxycycline on leucocyte membrane receptors. Naess A; Glette J; Halstensen AI; Sandberg S; Solberg CO Clin Exp Immunol; 1985 Nov; 62(2):310-4. PubMed ID: 2935335 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of the expression of eosinophil IgE receptor (Fc epsilon R2) and its function by platelet-activating factor. Walsh GM; Moqbel R; Nagakura T; Iikura Y; Kay AB J Lipid Mediat; 1990; 2 Suppl():S177-86. PubMed ID: 1966815 [TBL] [Abstract][Full Text] [Related]
14. Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils. Takafuji S; Tadokoro K; Ito K; Dahinden CA Int Arch Allergy Immunol; 1995; 108 Suppl 1():36-8. PubMed ID: 7549519 [TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. Wardlaw AJ; Moqbel R; Cromwell O; Kay AB J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451 [TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of human monocyte complement (C3b) receptors by chemoattractants. Glass EJ; Kay AB Clin Exp Immunol; 1980 Mar; 39(3):768-75. PubMed ID: 7379336 [TBL] [Abstract][Full Text] [Related]
19. Analysis of signal transduction pathways regulating cytokine-mediated Fc receptor activation on human eosinophils. Bracke M; Coffer PJ; Lammers JW; Koenderman L J Immunol; 1998 Dec; 161(12):6768-74. PubMed ID: 9862707 [TBL] [Abstract][Full Text] [Related]
20. Biological activities of ecalectin: a novel eosinophil-activating factor. Matsumoto R; Hirashima M; Kita H; Gleich GJ J Immunol; 2002 Feb; 168(4):1961-7. PubMed ID: 11823532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]